Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Cardiff Oncology, Inc.
Pharmaceutical Preparation ManufacturingUnited States
Last verified 10 months agocardiffoncology.com
Cardiff Oncology, Inc., a pioneering biotechnology firm headquartered in the United States, focuses on developing innovative therapies for cancer treatment. Founded in 2007, the company has made significant strides in the oncology sector, particularly with its lead product, onvansertib, which targets specific cancer pathways to enhance treatment efficacy.
With a strong presence in major operational regions, Cardiff Oncology is dedicated to advancing precision medicine and improving patient outcomes. The company has garnered attention for its unique approach to targeting KRAS mutations, positioning itself as a leader in the competitive oncology landscape. Notable achievements include successful clinical trials that underscore the potential of its therapies, solidifying Cardiff Oncology's reputation as a key player in the fight against cancer.
18
DitchCarbon score
-24 vs industry average
Cardiff Oncology, Inc.’s score of 18 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Cardiff Oncology, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Cardiff Oncology, Inc. yet.
Cardiff Oncology, Inc.'s reported carbon emissions
Cardiff Oncology, Inc., headquartered in the US, currently does not have available data on its carbon emissions, as indicated by the absence of reported figures. Consequently, there are no specific emissions totals or breakdowns by Scope 1, 2, or 3.
Furthermore, the company has not outlined any formal reduction targets or commitments to climate initiatives, such as those associated with the Science Based Targets initiative (SBTi) or other industry-standard climate pledges.
As a result, Cardiff Oncology's climate commitments remain unclear, and the company has not publicly disclosed any strategies or goals aimed at reducing its carbon footprint. This lack of data highlights a potential area for improvement in transparency regarding environmental impact and sustainability efforts within the biotechnology sector.
Assessing Cardiff Oncology, Inc. as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Cardiff Oncology, Inc. and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Cardiff Oncology, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Cardiff Oncology, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Cardiff Oncology, Inc.10 months ago
18
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more